Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Genotyping Kit for Target Alleles: Streamlined DNA Prep & An
2026-05-09
Accelerate molecular genotyping across insects, tissues, fishes, and cells with a single-tube solution that eliminates phenol extraction and reduces contamination risk. This workflow-focused article details applied use-cases, advanced troubleshooting, and protocol optimization for the Genotyping Kit for target alleles.
-
I-BET151 (GSK1210151A): Technical Guide for BET Inhibition A
2026-05-08
I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor optimized for modulating BRD2, BRD3, and BRD4 activity in cancer biology research, especially in apoptosis and cell cycle arrest assays. It is recommended for preclinical workflows and mechanistic studies, but is not suitable for diagnostic or clinical use. Proper handling, solubilization, and workflow design are essential to ensure robust and reproducible results.
-
Jiedu Xiaozheng Yin Induces M1 Macrophage Polarization via T
2026-05-08
Liu et al. (2024) demonstrate that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine compound, suppresses colitis-associated colorectal cancer (CAC) progression by promoting macrophage polarization toward the pro-inflammatory M1 phenotype through the TLR4 pathway. This mechanistic insight highlights the therapeutic promise of modulating innate immune responses in CAC and provides a foundation for integrating transcription factor inhibitors in cancer immunomodulation research.
-
Tumor-Targeted PAD4 Inhibition via PBA: Mechanistic Advances
2026-05-07
This study introduces phenylboronic acid (PBA)-modified PAD4 inhibitors that selectively target tumor and neutrophil PAD4 activity, suppressing tumor growth and metastasis by blocking the PAD4-H3cit-NETs pathway. The work offers a mechanistic rationale for highly specific antitumor intervention with reduced off-target toxicity.
-
Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa
2026-05-07
This study systematically dissects how nanoparticle size and PEGylation determine the fate of iron oxide nanoparticles in the liver. The findings revise established models by showing that hepatocytes and stellate cells, not Kupffer cells, are the primary mediators of hepatic nanoparticle uptake, guiding future nanomedicine design for improved targeting.
-
Thioguanine: Applied Protocols for Cancer and Antiviral Rese
2026-05-06
Thioguanine (6-thioguanine) transforms experimental workflows in oncology and virology with its dual antitumor and antiviral mechanisms. Explore scenario-driven protocols, troubleshooting insights, and the latest evidence on optimizing its use for robust, reproducible results.
-
Necrostatin-1: Advanced RIP1 Kinase Inhibition in Cell Death
2026-05-06
Discover the scientific depth of Necrostatin-1 as a potent RIP1 kinase inhibitor for necroptosis assays. This article provides advanced guidance on assay design, mechanistic insights, and practical considerations distinct from standard reviews.
-
Superoxide Dismutase Activity Assay Kit: Rethinking ROS Quan
2026-05-05
Explore the scientific and practical nuances of the Superoxide Dismutase Activity Assay Kit in advanced ROS measurement. This article uniquely examines how methodological precision and recent research insights shape reliable oxidative stress analysis.
-
Berberrubine Chloride: Mechanistic Insights for Translationa
2026-05-05
This article explores the multifaceted mechanistic actions of Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride), bridging its molecular targets to strategic translational opportunities in oncology, infectious disease, and metabolic disorders. Drawing from recent primary literature and APExBIO’s rigorous workflows, we provide evidence-based guidance and practical protocol parameters for researchers seeking to translate bench discoveries into preclinical impact.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In
2026-05-04
Wang et al. (2018) systematically demonstrated that genotype III grass carp reovirus (GCRV104) enters host cells via clathrin-mediated, pH-dependent endocytosis. Their comprehensive inhibitor profiling clarified critical cellular pathways involved in viral entry, shaping future antiviral research and the rational selection of pathway-specific inhibitors.
-
DAPI (hydrochloride) in Cell Cycle Analysis and Chemoresista
2026-05-04
DAPI (hydrochloride) is a gold-standard DNA visualization dye, enabling precise cell cycle analysis and multiplexed histochemistry, especially in complex microenvironments. This article translates new mechanobiology findings into actionable workflows, protocol enhancements, and troubleshooting insights for researchers leveraging APExBIO's high-purity DAPI (hydrochloride).
-
TQB3720 Induces Ferroptosis via AR/GPX4 Axis in Prostate Can
2026-05-03
Zhang et al. demonstrate that the second-generation AR antagonist TQB3720 suppresses prostate cancer cell growth by promoting ferroptosis through inhibition of the AR/SP1-GPX4 transcriptional axis. This mechanistic insight advances therapeutic strategies targeting androgen signaling and ferroptosis in prostate cancer.
-
Entecavir (BMS200475): Molecular Pharmacology and Clinical T
2026-05-02
Explore the molecular pharmacology of Entecavir, a leading agent in chronic hepatitis B virus replication inhibition. This in-depth analysis uniquely bridges molecular mechanism with clinical translation, offering new insights for advanced HBV research and therapy.
-
S-Adenosylmethionine (SAM): Reliable Solutions for Cell Assa
2026-05-02
This article delivers practical, evidence-based guidance for leveraging S-Adenosylmethionine (SAM, SKU B3513) in cell viability, proliferation, and cytotoxicity assays. Readers will find scenario-driven answers to laboratory challenges, quantitative protocol recommendations, and vendor comparisons—anchored by APExBIO’s high-purity formulation and workflow-proven reliability.
-
Brefeldin A: Mechanistic Unraveling and Translational Value
2026-05-01
Explore the multifaceted mechanisms of Brefeldin A (BFA) as an ER stress inducer and apoptosis modulator in cancer and endothelial injury models. This article delivers a unique, practical guide—bridging molecular detail with assay strategy and translational relevance.